HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Napoleone Ferrara Selected Research

Blocking Antibodies

1/2020Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer.
4/2010PlGF blockade does not inhibit angiogenesis during primary tumor growth.
2/2007Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library.
1/2006Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Napoleone Ferrara Research Topics

Disease

75Neoplasms (Cancer)
01/2020 - 03/2002
21Macular Degeneration (Age-Related Maculopathy)
01/2016 - 12/2002
11Pathologic Neovascularization
01/2016 - 12/2002
11Hypoxia (Hypoxemia)
02/2013 - 01/2002
10Carcinogenesis
01/2020 - 03/2002
8Neoplasm Metastasis (Metastasis)
01/2020 - 11/2009
6Inflammation (Inflammations)
01/2020 - 11/2004
6Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 06/2004
5Choroidal Neovascularization
08/2013 - 11/2005
4Infertility (Sterility)
01/2018 - 03/2004
3Ovarian Neoplasms (Ovarian Cancer)
11/2017 - 11/2002
3Ischemia
05/2014 - 04/2010
3Ascites
11/2006 - 11/2002
2Pain (Aches)
01/2018 - 06/2015
2Cognitive Dysfunction
08/2016 - 05/2016
2Obesity
08/2016 - 05/2016
2Hyperglycemia
02/2015 - 01/2014
2Disease Progression
02/2010 - 06/2004
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2007 - 02/2007
2Carcinoma (Carcinomatosis)
05/2006 - 11/2002
2Diabetic Retinopathy (Retinopathy, Diabetic)
07/2005 - 08/2004
2Neointima
10/2004 - 01/2002
1Geographic Atrophy
11/2022
1Retinal Neovascularization
12/2020
1Colitis
01/2020
1Squamous Cell Carcinoma of Head and Neck
01/2020
1Communicable Diseases (Infectious Diseases)
01/2020
1Eye Diseases (Eye Disease)
01/2019
1Breast Neoplasms (Breast Cancer)
10/2018
1Kallmann Syndrome (Kallmann's Syndrome)
01/2018
1Alzheimer Disease (Alzheimer's Disease)
05/2016
1Neuroinflammatory Diseases
05/2016
1Glioma (Gliomas)
01/2016
1Glioblastoma (Glioblastoma Multiforme)
01/2016
1Cancer Pain
06/2015
1Cardiovascular Diseases (Cardiovascular Disease)
05/2014
1Prostatic Neoplasms (Prostate Cancer)
07/2013
1Blindness (Hysterical Blindness)
06/2013

Drug/Important Bio-Agent (IBA)

87Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 01/2002
18Monoclonal AntibodiesIBA
01/2016 - 11/2002
17Bevacizumab (Avastin)FDA Link
11/2017 - 12/2002
15AntibodiesIBA
01/2018 - 07/2004
7Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 07/2008
7Proteins (Proteins, Gene)FDA Link
01/2020 - 07/2004
6Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018 - 01/2004
6Angiogenesis InhibitorsIBA
01/2016 - 07/2004
5LigandsIBA
06/2015 - 03/2002
4MitogensIBA
11/2022 - 05/2006
4Protein Isoforms (Isoforms)IBA
01/2020 - 03/2003
4Pharmaceutical PreparationsIBA
01/2020 - 07/2004
4Blocking AntibodiesIBA
01/2020 - 01/2006
4Neutralizing AntibodiesIBA
01/2019 - 01/2009
4Retinaldehyde (Retinal)IBA
01/2016 - 07/2010
4Transcription Factors (Transcription Factor)IBA
02/2009 - 03/2003
3CytokinesIBA
01/2019 - 04/2009
3Biomarkers (Surrogate Marker)IBA
11/2017 - 11/2009
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2015 - 07/2002
3platelet-derived growth factor C (PDGF-C)IBA
02/2015 - 01/2009
3Endocrine-Gland-Derived Vascular Endothelial Growth Factor (Vascular Endothelial Growth Factor, Endocrine Gland Derived)IBA
08/2004 - 06/2003
2IronIBA
01/2020 - 10/2018
2Conditioned Culture MediaIBA
10/2018 - 05/2006
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10/2018 - 04/2009
2Biological ProductsIBA
01/2018 - 05/2011
2Glucose (Dextrose)FDA LinkGeneric
08/2016 - 05/2016
2Ranibizumab (Lucentis)FDA Link
01/2016 - 10/2006
2Neuropilin-1IBA
02/2013 - 01/2010
2Sunitinib (Sutent)FDA Link
08/2012 - 08/2012
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
07/2011 - 04/2010
2Immunoglobulin G (IgG)IBA
04/2010 - 07/2004
2Placenta Growth FactorIBA
04/2010 - 04/2009
2AntigensIBA
10/2006 - 08/2004
2Chemotactic FactorsIBA
05/2006 - 07/2004
2platelet-derived growth factor AIBA
05/2006 - 07/2004
2Paclitaxel (Taxol)FDA LinkGeneric
02/2005 - 11/2002
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
08/2004 - 08/2003
2Fluorouracil (Carac)FDA LinkGeneric
07/2004 - 06/2004
1tipifarnib (R115777)IBA
01/2020
1Nucleic AcidsIBA
01/2020
1Iron-Binding ProteinsIBA
01/2020
1Interleukin-22 (IL-22)IBA
01/2019
1Transferrin (beta 2 Transferrin)IBA
10/2018
1Janus KinasesIBA
10/2018
1Transferrin Receptors (Transferrin Receptor)IBA
10/2018
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2018
1pegaptanib (Macugen)FDA Link
01/2016
1Vascular Endothelial Growth Factor BIBA
06/2015
1Streptozocin (Streptozotocin)FDA Link
05/2014
1AntioxidantsIBA
01/2014
1Therapeutic UsesIBA
09/2013
1Interleukin-17 ReceptorsIBA
09/2013
1Interleukin-17 (Interleukin 17)IBA
09/2013
1Phosphotransferases (Kinase)IBA
09/2013
1TOR Serine-Threonine KinasesIBA
07/2013
1MTOR InhibitorsIBA
07/2013

Therapy/Procedure

40Therapeutics
01/2020 - 11/2002
7Drug Therapy (Chemotherapy)
06/2007 - 01/2004
4Lasers (Laser)
08/2013 - 02/2008
2Radiotherapy
02/2005 - 01/2004
1Intraocular Injections
12/2020
1Immunotherapy
01/2019